N‐(4‐Biphenylmethyl)imidazoles as Potential Therapeutics for the Treatment of Prostate Cancer: Metabolic Robustness Due to Fluorine Substitution?
- 1 July 2003
- journal article
- research article
- Published by Wiley in Helvetica Chimica Acta
- Vol. 86 (7), 2671-2686
- https://doi.org/10.1002/hlca.200390217
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Inhibition of CYP 17, a New Strategy for the Treatment of Prostate CancerArchiv der Pharmazie, 2002
- Fluorophenols and (Trifluoromethyl)phenols as Substrates of Site-Selective Metalation Reactions: To Protect or not To ProtectEuropean Journal of Organic Chemistry, 2001
- Cytochrome P450 3. Clinically Significant Drug InteractionsThe Australian Journal of Hospital Pharmacy, 2000
- Fluorine-Sacrificial Cyclizations as an Access to 5-FluoropyrazolesEuropean Journal of Organic Chemistry, 2000
- Parametrization of Substituents: Effects of Fluorine and Other Heteroatoms on OH, NH, and CH AciditiesAngewandte Chemie International Edition, 1998
- Parametrisierung von Substituenten – der Einfluß von Fluor und anderen Heteroatomen auf OH-, NH- und CH-AciditätenAngewandte Chemie, 1998
- About the “physiological size” of fluorine substituents: Comparison of sensorially active compounds with fluorine and methyl substituted analoguesTetrahedron, 1996
- Structure and barrier of internal rotation of biphenyl derivatives in the gaseous stateJournal of Molecular Structure, 1985
- Introduction of fluorine into organic molecules: why and howTetrahedron, 1978
- Selektive Synthesen mit Organometallen IV: Gezielte Hydroxylierung von AllylstellungenHelvetica Chimica Acta, 1975